Effects of Treatment With Omacor for 6 Weeks on Preprandial and Postprandial Endothelial Function Following a High Fat Meal in Patients With Type 2 Diabetes Mellitus
Sponsor study identifier
interventional
34
1 country
1
Study Start
April 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2008
Actual (reported)Study Completion
November 2008
Actual (reported)The purpose of the study is to determine whether a 6-week treatment with 4 g Omacor/day improves the baseline and postprandial endothelial function (after a high-fat meal) in patients with type 2 diabetes mellitus.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2008
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 19, 2006
Actual (reported)May 22, 2006
Actual (reported)April 2007
Date type not reportedThis date has not been verified as actual or estimated.
November 2008
Actual (reported)November 2008
Actual (reported)Postprandial (2, 4 and 6 hours) flow-mediated vasodilation after a 6-week treatment with Omacor
Baseline flow-mediated vasodilation after a 6-week treatment with Omacor
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Heart- and Diabetes Centre NRW, Diabetes Clinic
Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
Stirban A, Nandrean S, Gotting C, Stratmann B, Tschoepe D. Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus. Horm Metab Res. 2014 Jun;46(7):490-2. doi: 10.1055/s-0033-1363225. Epub 2013 Dec 19.
Diethelm Tschoepe, MD, Prof.
Heart and Diabetes Center North-Rhine Westfalia
Alin Stirban, MD
Heart and Diabetes Center North-Rhine Westfalia
First Submitted
May 19, 2006
First Posted
May 22, 2006
Study Start
April 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2008
Actual (reported)Clopidogrel Versus Cilostazol on Vessels
Contact the study team to confirm eligibility.
Study Completion
November 2008
Actual (reported)Last Updated
May 8, 2009
Record last verified: 2009-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: